REG - AstraZeneca PLC - Annual Financial Report <Origin Href="QuoteRef">AZN.L</Origin> - Part 40
08/03/2016 12:10
- Part 40: For the preceding part double click ID:nRSH4027RM
in collateralised bank deposits or AAA credit rated institutional money
market funds. Money market funds are backed by institutions in the US and
the EU, which, in turn, invest in other funds, including sovereign funds.
This means our credit exposure is a mix of US and EU sovereign default
risk and financial institution default risk. Fluctuations in exchange
ratesAs a global business, currency fluctuations can significantly affect
our results of operations, which are reported in US dollars.
Approximately 40% of our global 2015 Product Sales were in the US, which
is expected to remain our largest single market for the foreseeable
future. Product Sales in other countries are predominantly in currencies
other than the US dollar, including the euro, Japanese yen, Chinese
- More to follow, for following part double click ID:nRSH4027RORecent news on AstraZeneca
See all newsREG - AstraZeneca PLC - Notification of Admission of Shares
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in EU for early gastric cancer
AnnouncementREG - AstraZeneca PLC - Notice of AGM
AnnouncementRCS - Redx Pharma Limited - RXC008 Receives US FDA Fast Track Designation
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
Announcement